Tirzepatide vs. Semaglutide for Weight Loss: What's the Difference?

If you are exploring GLP-1 weight loss treatment, you have probably come across both tirzepatide and semaglutide. Both are prescription injectable medications that help reduce appetite and support meaningful weight loss — but they work a little differently and produce different average results in clinical trials.

Here is a plain-language breakdown.

How they work

Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after eating that signals fullness and slows digestion. Semaglutide mimics this hormone, helping you feel satisfied with less food. It is the active ingredient in Ozempic and Wegovy.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. In addition to activating the GLP-1 pathway, it also activates GIP — another gut hormone that plays a role in insulin regulation and fat storage. This dual action is thought to be why tirzepatide produces higher average weight loss in trials. It is the active ingredient in Mounjaro and Zepbound.

What the research shows

In the SURMOUNT-1 trial, people taking the highest dose of tirzepatide lost an average of 22.5% of their body weight over 72 weeks. In the STEP 1 trial, semaglutide at its highest dose produced an average weight loss of 14.9% over 68 weeks.

Both are significantly more effective than diet and exercise alone. Tirzepatide’s advantage in average results is meaningful, but individual response varies widely — some people do exceptionally well on semaglutide, and not everyone responds the same way to either medication.

Side effects

Both medications share similar side effect profiles, largely related to their effects on digestion:

• Nausea (especially early in treatment)
• Vomiting
• Diarrhea or constipation
• Decreased appetite

Starting at a low dose and titrating slowly — as both medications require — helps most people manage these effects. Tirzepatide’s side effects are broadly similar to semaglutide’s, though individual experience differs.

How to choose

Neither medication is universally better. The right choice depends on:

• Your health history and any contraindications
• How your body has responded to prior treatments
• Your provider’s clinical judgment

A licensed provider — not an algorithm or a quiz — should make this decision with you based on your full picture. With Renlo, your provider reviews your intake and recommends a treatment plan that fits your specific situation. You can explore semaglutide and tirzepatide on our site, and your provider will help determine which is appropriate for you.

Cost

Brand-name versions of both medications remain expensive without insurance coverage. Compounded semaglutide and compounded tirzepatide, dispensed by licensed U.S. pharmacies, are available at significantly lower cost through telehealth providers like Renlo.

---

This article is for general educational purposes only and is not medical advice. Treatment decisions should be made with a licensed provider based on your individual health history.